Thompson Siegel & Walmsley’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Thompson Siegel & Walmsley’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Hold	8,000	–	–	0.02%	310
2026 Q1	$1.02M	Hold	8,000	–	–	0.02%	320
2025 Q4	$975K	Hold	8,000	–	–	0.02%	311
2025 Q3	$802K	Hold	8,000	–	–	0.01%	328
2025 Q2	$663K	Sell	8,000 -200	-2%	-$16K	0.01%	326
2025 Q1	$665K	Hold	8,200	–	–	0.01%	315
2024 Q4	$738K	Sell	8,200 -1,350	-14%	-$131K	0.01%	298
2024 Q3	$944K	Hold	9,550	–	–	0.01%	294
2024 Q2	$885K	Sell	9,550 -25	-0.3%	-$2.24K	0.01%	282
2024 Q1	$909K	Hold	9,575	–	–	0.01%	282
2023 Q4	$855K	Hold	9,575	–	–	0.01%	277
2023 Q3	$699K	Hold	9,575	–	–	0.01%	286
2023 Q2	$797K	Hold	9,575	–	–	0.01%	284
2023 Q1	$730K	Hold	9,575	–	–	0.01%	284
2022 Q4	$795K	Hold	9,575	–	–	0.01%	266
2022 Q3	$759K	Hold	9,575	–	–	0.01%	272
2022 Q2	$711K	Hold	9,575	–	–	0.01%	281
2022 Q1	$861K	Hold	9,575	–	–	0.01%	277
2021 Q4	$1.07M	Hold	9,575	–	–	0.01%	262
2021 Q3	$1.2M	Hold	9,575	–	–	0.02%	256
2021 Q2	$1.3M	Buy	9,575 +1,000	+12%	+$131K	0.02%	257
2021 Q1	$1.16M	Buy	8,575 +7,575	+758%	+$1.13M	0.02%	240
2020 Q4	$141K	Buy	1,000 +985	+6,567%	+$126K	﹤0.01%	356
2020 Q3	$2K	Hold	15	–	–	﹤0.01%	633
2020 Q2	$2K	Buy	+15	New	+$1.48K	﹤0.01%	640

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Thompson Siegel & Walmsley's XBI Position: Q2 2026 in Review

Thompson Siegel & Walmsley held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 8,000 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #310.

Thompson Siegel & Walmsley first reported a position in XBI in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.3M in Q2 2021. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Thompson Siegel & Walmsley held 8,000 shares of State Street SPDR S&P Biotech ETF worth $1.27M as of Q2 2026.
Thompson Siegel & Walmsley left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #310 holding.
Thompson Siegel & Walmsley first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 25 quarters since.
Thompson Siegel & Walmsley's State Street SPDR S&P Biotech ETF position peaked at $1.3M in Q2 2021.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.